AMH as part of the diagnostic PCOS workup in large epidemiological studies

Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome

(2022) Loes M E Moolhuijsen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study

(2021) Marina A Skiba et al.   HUMAN REPRODUCTION

Cohort Profile: 46 years of follow-up of the Northern Finland Birth Cohort 1966 (NFBC1966)

(2021) Tanja Nordström et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome

(2021) Fahimeh Ramezani Tehrani et al.   Reproductive Biology and Endocrinology

Antimüllerian hormone to determine polycystic ovarian morphology

(2021) Alexandra Dietz de Loos et al.   FERTILITY AND STERILITY

Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study

(2021) Robin J Bell et al.   HUMAN REPRODUCTION

Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome

(2020) Osman Evliyaoglu et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term

(2019) Terhi T. Piltonen et al.   FERTILITY AND STERILITY

Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes

(2019) Henri Sova et al.   GYNECOLOGICAL ENDOCRINOLOGY

Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines

(2019) Helena Teede et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

(2018) Helena J. Teede et al.   CLINICAL ENDOCRINOLOGY

OUP accepted manuscript

(2018)   HUMAN REPRODUCTION UPDATE

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood

(2018) Brooke Tata et al.   NATURE MEDICINE

Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up

(2017) Salla Karjula et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination

(2016) E. Anckaert et al.   CLINICAL BIOCHEMISTRY

Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome

(2016) S.L. Jacob et al.   CLINICAL ENDOCRINOLOGY

Criteria, prevalence, and phenotypes of polycystic ovary syndrome

(2016) Daria Lizneva et al.   FERTILITY AND STERILITY

Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus—a prospective, population-based cohort study

(2016) M.-M.E. Ollila et al.   HUMAN REPRODUCTION

Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study

(2016) Meri-Maija E. Ollila et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion

(2016) Irene Cimino et al.   Nature Communications

Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay

(2015) Josef van Helden et al.   HUMAN REPRODUCTION

The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone

(2014) M. P. Lauritsen et al.   HUMAN REPRODUCTION

The physiology and clinical utility of anti-Müllerian hormone in women

(2014) Didier Dewailly et al.   HUMAN REPRODUCTION UPDATE

Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms

(2013) Sezai Sahmay et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

(2012) T. B. Eilertsen et al.   HUMAN REPRODUCTION

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria

(2012) B. O. Yildiz et al.   HUMAN REPRODUCTION

Serum Anti-Müllerian Hormone Levels in Healthy Females: A Nomogram Ranging from Infancy to Adulthood

(2012) S. Lie Fong et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells

(2011) Laura Pellatt et al.   FERTILITY AND STERILITY

The antral follicle count: practical recommendations for better standardization

(2009) Frank J.M. Broekmans et al.   FERTILITY AND STERILITY

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

(2009) W. A. March et al.   HUMAN REPRODUCTION

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

(2009) Lisa Moran et al.   HUMAN REPRODUCTION UPDATE